Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

NCT06125951 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia Moderate
Dementia, Mild
Alzheimer Disease

Interventions

DRUG: Xanamem
DRUG: Placebo

Sponsor

Actinogen Medical